Navigation Links
Abbott Declares 343rd Consecutive Quarterly Dividend
Date:9/17/2009

ABBOTT PARK, Ill., Sept. 17 /PRNewswire-FirstCall/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 40 cents per share.

This marks the 343rd consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Nov. 15, 2009, to shareholders of record at the close of business on Oct. 15, 2009.

Abbott has increased its dividend payout for 37 consecutive years - including an 11 percent increase earlier this year - and was again named to the Fortune 40: Best stocks to retire on. Additionally, Abbott is a top performer of the S&P 500 Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for 25 consecutive years.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 72,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.


'/>"/>
SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Abbott Wins Top Honor in Wall Street Journal Technology Innovation Awards
2. Abbott Announces Approval in China for Next-Generation XIENCE V(R) Drug Eluting Stent
3. Abbott to Acquire Evalve, Inc., a Leader in Minimally Invasive Cardiac Valve Repair Technology
4. Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial
5. Abbott HIV Test Demonstrates Earlier Disease Detection
6. Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories
7. Abbott & BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays
8. Abbott Named One of the Top 10 Companies for Scientists
9. HUYA Bioscience Announces Strategic Alliance With Abbott on Drug and Biomarker Development Candidates From China
10. Abbott to Present at Barclays Global Healthcare Conference
11. Abbott Employee Giving Sets New Records for Employee Participation and Total Donations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... Sterlitech is proud to offer Synder ... PY, and PZ Polyacrylonotrile (PAN) membranes , as ... to be ideal for oil removal in wastewater ... process requirements where the presence of oils in ... on industrial wastewater discharge and quality requirements for ...
(Date:4/29/2015)... 2015 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced ... Biorem,s complete fiscal 2014 year-end financial statements and MD&A have been filed ... 2013 , 2014 , 2013 Revenue 3,968 ... Gross profit 1,326 , 1,703 , 2,231 ... , 3,377 , 4,562 Ebitda* 92 , ...
(Date:4/29/2015)... 2015 AlloSource ®, one of ... skin and soft-tissue allografts for use in surgical ... announced the launch of AlloSkin™ AC, an acellular ... Services (CMS) also moved AlloSkin™ RT, a meshed ... high-cost category for reimbursement. "AlloSource is ...
(Date:4/29/2015)... , April 29, 2015 /CNW/ - Northern Biologics Inc., ... Ventures, today announced an exclusive, strategic collaboration with ... Biologics received a US$30 million upfront cash payment. ... develop first-in-class therapeutic antibodies, and will have the ... the advancement of its portfolio. ...
Breaking Biology Technology:Sterlitech Offers New Ultrafiltration Membranes 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 3Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 4AlloSource Announces New Possibilities In Wound Care 2Northern Biologics and Celgene Enter Strategic Collaboration 2
... ANNAPOLIS, Md., March 20 PharmAthene, Inc.,(Amex: ... against,biological and chemical threats, today reported the company ... ended December 31, 2007. The earnings,release was previously ... the new date and time of its earnings ...
... Hutchinson Cancer Research,Center (FHCRC) and NSB POSTECH, Inc. ... efforts and to determine the efficacy of the,NSB,s ... to be used in the study of human ... company which possesses a proprietary,microarray technology and a ...
... non-healing leg ulcers each year in the US, ... (OTC Bulletin Board: DSCI), provider of advanced wound ... abstracts detailing the clinical usage,of its newly released ... presented at the annual American Professional Wound Care,Association ...
Cached Biology Technology:Fred Hutchinson Cancer Research Center and NSB POSTECH, Inc. to Collaborate on Development of New Class of Proteomic Microarrays 2Derma Sciences Announces Clinical Poster on Use of MEDIHONEY(TM) Wound & Burn Dressings Wins First Place Award at APWCA 2Derma Sciences Announces Clinical Poster on Use of MEDIHONEY(TM) Wound & Burn Dressings Wins First Place Award at APWCA 3Derma Sciences Announces Clinical Poster on Use of MEDIHONEY(TM) Wound & Burn Dressings Wins First Place Award at APWCA 4
(Date:4/2/2015)... -- According to preliminary estimates Fingerprint Cards, ... than 125 MSEK. This exceeds the guidance provided by ... for Q1 2015 would be in line with the ... The operating result for the first quarter is estimated ... will as previously communicated be published on May 21. ...
(Date:4/1/2015)...   Medisafe ™, the leading global medication management ... and Android smartphones and tablets, announces ... platform to allow patients to track and correlate their ... patients will be able to visualize in real-time how ... such as glucose levels and blood pressure. ...
(Date:3/30/2015)... Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) ... Recognition Market in Automotive Sector 2014-2018" report to ... Gesture Recognition market in Automotive Sector to grow at ... Gesture recognition is the ability of a device ... individual. Gesture recognition technology can be 2D-based or 3D-based. ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... London) finds that a high-prevalence of male-killing bacteria active in ... promiscuity and male fatigue. , The team found that when ... bacteria -- the female butterfly becomes more sexually rampant. Males ... less effort into mating. , In some populations ...
... flu virus's hemagglutinin receptor binding site—a molecular structure critical ... according to a new study conducted by researchers at ... for Disease Control and Prevention. The finding, published in ... clinical implications in helping scientists develop ways to break ...
... a team of University of Georgia scientists suggests that ... do little ?if anything ?to reduce rates of antibiotic ... health. , Dr. Margie Lee, professor in the ... found that chickens raised on antibiotic-free farms and even ...
Cached Biology News:Male-killing bacteria makes female butterflies more promiscuous 2Changes in amino acids in the 1918 influenza virus cut transmission 2Changes in amino acids in the 1918 influenza virus cut transmission 3Study finds antibiotic resistance in poultry even when antibiotics were not used 2Study finds antibiotic resistance in poultry even when antibiotics were not used 3
Human DC-SIGNR/CD209L MAb (Clone 120604)...
Human DPPII/QPP/DPP7 Biotinylated Affinity Purified PAb ENTREZ GeneID: 29952...
Human SorCS1 Affinity Purified Polyclonal Ab Protein Family: Neurotrophins...
Human Apolipoprotein B100 Affinity Purified Polyclonal Ab ENTREZ GeneID: 338...
Biology Products: